Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Colombian Journal of Anestesiology
versión impresa ISSN 0120-3347
Resumen
BOTERO POSADA, Luis Fernando; ARIAS JIMENEZ, Juan Miguel y VASSEUR ARBOLEDA, Juan Pablo. The Use of Dexmedetomidine (DXM) for Implanting a Cardiac Resynchronization Device: Is it Really Safe?. Rev. colomb. anestesiol. [online]. 2011, vol.39, n.3, pp.425-431. ISSN 0120-3347. https://doi.org/10.5554/rca.v39i3.99.
Dexmedetomidine (DXM) is a selective 2-adrenoreceptor agonist acting over both the central and peripheral nervous system. Since it became available for medical application, DXM has been satisfactorily used for a broad spectrum of anesthetic procedures, ranging from sedation to interventions under general anesthesia. Its key advantages include its hemodynamic stability and minimal respiratory depression. This article provides a description of a successful cardiac resynchronization therapy implanting a biventricular pacemaker in a hemodynamically unstable patient under DXM and low-dose midazolam sedation.
Palabras clave : Dexmedetomidine; biological clocks; amiodarone; safety measures.